A Real-World Study of Long-Term Safety and Efficacy of Lobeglitazone in Korean Patients with Type 2 Diabetes Mellitus

A Real-World Study of Long-Term Safety and Efficacy of Lobeglitazone in Korean Patients with Type 2 Diabetes Mellitus

Background Thiazolidinediones (TZDs) have been associated with various safety concerns including weight gain, bladder cancer, and congestive heart failure (CHF). This study evaluated the efficacy and safety of lobeglitazone, a novel TZD in patients with type 2 diabetes mellitus (T2DM) in real practi...

Full description

Bibliographic Details
Main Authors: Bo-Yeon Kim, Hyuk-Sang Kwon, Suk Kyeong Kim, Jung-Hyun Noh, Cheol-Young Park, Hyeong-Kyu Park, Kee-Ho Song, Jong Chul Won, Jae Myung Yu, Mi Young Lee, Jae Hyuk Lee, Soo Lim, Sung Wan Chun, In-Kyung Jeong, Choon Hee Chung, Seung Jin Han, Hee-Seok Kim, Ju-Young Min, Sungrae Kim
Format: Article
Language:English
Published: Korean Diabetes Association 2022-11-01
Series:Diabetes & Metabolism Journal
Subjects:
diabetes mellitus
type 2
lobeglitazone
observational study
thiazolidinediones
Online Access:http://e-dmj.org/upload/pdf/dmj-2021-0264.pdf

Internet

http://e-dmj.org/upload/pdf/dmj-2021-0264.pdf

Similar Items